Publications
291
Citations
8,781
Est. group size
—
Recurring co-author estimate
Active years
52
Publishing since 1975
Monika Fischer conducts clinical research in gastroenterology, focusing on Clostridioides difficile infection (a serious bacterial gut infection often triggered by antibiotic use) and its treatment through fecal microbiota transplantation (transferring healthy gut bacteria from a donor to a patient). Her work also addresses inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, including drug trials and clinical management guidelines. Much of her output involves multi-center studies and expert consensus documents that shape clinical practice.
Publication activity was high in the late 2010s (around 30-38 per year) and has since decreased to roughly 10 per year in the most recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Clostridioides difficile Infection: Harmonizing Patient Care
Gastro Hep Advances · 2026
- Sa1378 CLOSTRIDIOIDES DIFFICILE INFECTION AND COLORECTAL CANCER RISK
Gastroenterology · 2026
- Sa1378 CLOSTRIDIOIDES DIFFICILE INFECTION AND COLORECTAL CANCER RISK
Gastrointestinal Endoscopy · 2026
- Treatment of Severe and Fulminant Clostridioides difficile Infections
Gastroenterology Clinics of North America · 2026
- AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review
Clinical Gastroenterology and Hepatology · 2026
- Colonoscopic or Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: A Prospective Cohort
Gastro Hep Advances · 2026
- The Management of Fulminant C. difficile Infection in an Immunocompromised Patient: Balancing Risk and Necessity
Gastroenterology · 2026
- Preferred Reporting Items for Microbiotherapy (PRIM) Guidelines Across Medical Disciplines: An International Delphi Consensus
Journal of Gastroenterology and Hepatology · 2025
- Safety and Efficacy of Fecal Microbiota, Live-jslm, in Preventing Recurrent <i>Clostridioides difficile</i> Infection in Participants Who Were Mildly to Moderately Immunocompromised in the Phase 3 PUNCH CD3-OLS Study
Open Forum Infectious Diseases · 2025
- What’s New and What’s Next in Fecal Microbiota Transplantation?
Biologics · 2025
- Diagnostic Uncertainties and Delayed Treatment Protocols Impact Efficacy of FMT for <i>Clostridioides difficile</i> Infection
Clinical Infectious Diseases · 2025
- Risk Factors for Antibiotic Exposure Post Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection, A Prospective Multicenter Observational Study
Open Forum Infectious Diseases · 2025
- Efficacy and safety of Long-term mirikizumab treatment in patients with moderate-to-severe crohn’s disease
Zeitschrift für Gastroenterologie · 2025
- S2141 Antibiotic Exposure Is a Short- and Long-Term Risk for Recurrent Clostridioides difficile Infection Following Fecal Microbiota Transplantation
The American Journal of Gastroenterology · 2025
- International consensus statement on microbiome testing in clinical practice
The Lancet. Gastroenterology & hepatology · 2024
- Gastroenterology×63
- The American Journal of Gastroenterology×43
- Clinical Gastroenterology and Hepatology×13
- Journal of Crohn s and Colitis×10
- Inflammatory Bowel Diseases×8
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile